Skip to main content
Erschienen in: Journal of Nephrology 4/2015

01.08.2015 | Original Article

Structured clinical follow-up for CKD stage 5 may safely postpone dialysis

verfasst von: Pietro Dattolo, Stefano Michelassi, Marco Amidone, Marco Allinovi, Lorenzo Vignali, Giulia Antognoli, Rosa Roperto, Francesco Pizzarelli

Erschienen in: Journal of Nephrology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Background and objectives

The optimal timing of dialysis initiation is still unclear. We aimed to ascertain whether a strict clinical follow-up can postpone need for dialysis in chronic kidney disease (CKD) stage 5 patients.

Design, setting, participants and measurements

We reviewed records of all consecutive adult patients attending our conservative CKD stage 5 outpatient clinic from 2001 to 2010. Chronicity was defined as two consecutive estimated glomerular filtration rate (eGFR) measurements below 15 ml/min/1.73 m2. Characteristics of subjects, including comorbidities, were assessed at baseline; blood pressure and serum markers of uremia were assessed both at first and last visit. GFR was estimated by the 4-variable Modification of Diet in Renal Disease (MDRD) formula.

Results

In the 312 patients analyzed baseline eGFR was 9.7 ± 2.7 ml/min, which declined by 1.93 ± 4.56 ml/min after 15.6 ± 18.2 months. Age was inversely related to eGFR decline (r −0.27, p = 0.000). During conservative follow-up 55 subjects (18 %) died. In comparison with those eventually entering dialysis, deceased subjects were older and had a longer follow-up with no CKD progression. Multivariate analysis identified age, proteinuria and lower baseline K values as the only independent determinants of death. One hundred ninety-four subjects (66 %) started dialysis with an average eGFR of 6.1 ± 1.9 ml/min. During 35.8 ± 24.7 months of dialysis follow-up, 84 patients died. Multivariate analysis identified age as the main determinant of death (hazard ratio [HR] for every year 1.07, 95 % confidence interval [CI] 1.04–1.11, p 0.000). Patients starting dialysis with eGFR below the median, e.g. <5.7 ml/min, showed a better survival (HR for mortality 0.52, 95 % CI 0.30–0.89, p 0.016) than the other group.

Conclusions

A well-organized nephrological outpatient clinic for conservative follow-up of CKD stage five patients can delay dialysis entry as long as 1 year. Starting dialysis with eGFR lower than 6 ml/min does not confer any increased risk of death in selected early-referral patients.
Literatur
1.
Zurück zum Zitat National Kidney Foundation (2006) KDOQI Clinical practice guidelines and clinical practice recommendations for 2006 updates: hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis 48:S1–S322CrossRef National Kidney Foundation (2006) KDOQI Clinical practice guidelines and clinical practice recommendations for 2006 updates: hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis 48:S1–S322CrossRef
2.
Zurück zum Zitat Kelly J, Stanley M, Harris D (2005) Caring for Australians with renal impairment (CARI). The CARI guidelines: acceptance into dialysis guidelines. Nephrology (Carlton) 10:S46–S60CrossRef Kelly J, Stanley M, Harris D (2005) Caring for Australians with renal impairment (CARI). The CARI guidelines: acceptance into dialysis guidelines. Nephrology (Carlton) 10:S46–S60CrossRef
3.
Zurück zum Zitat European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association (2002). Nephrol Dial Transpl 17(S7):S10–S11 European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association (2002). Nephrol Dial Transpl 17(S7):S10–S11
4.
Zurück zum Zitat National Kidney Foundation, United States Renal Data System (2008) 2007 Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Am J Kidney Dis 51(S1):S33–S48 National Kidney Foundation, United States Renal Data System (2008) 2007 Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Am J Kidney Dis 51(S1):S33–S48
5.
Zurück zum Zitat Rosansky SJ, Clark WF, Eggers P, Glassock RJ (2009) Initiation of dialysis at higher GFRs: is the apparent rising tide of early dialysis harmful or helpful? Kidney Int 76:257–261PubMedCrossRef Rosansky SJ, Clark WF, Eggers P, Glassock RJ (2009) Initiation of dialysis at higher GFRs: is the apparent rising tide of early dialysis harmful or helpful? Kidney Int 76:257–261PubMedCrossRef
6.
Zurück zum Zitat Stel VS, Tomson C, Ansell D et al (2010) Level of renal function in patients starting dialysis: an ERA-EDTA Registry study. Nephrol Dial Transpl 25:3315–3325CrossRef Stel VS, Tomson C, Ansell D et al (2010) Level of renal function in patients starting dialysis: an ERA-EDTA Registry study. Nephrol Dial Transpl 25:3315–3325CrossRef
7.
Zurück zum Zitat van de Luijtgaarden MW, Noordzij M, Tomson C et al (2012) Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologists. Am J Kidney Dis 60(6):940–948PubMedCrossRef van de Luijtgaarden MW, Noordzij M, Tomson C et al (2012) Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologists. Am J Kidney Dis 60(6):940–948PubMedCrossRef
8.
Zurück zum Zitat Traynor JP, Simpson K, Geddes CC, Deighan CJ, Fox JG (2002) Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure. J Am Soc Nephrol 13:2125–2132PubMedCrossRef Traynor JP, Simpson K, Geddes CC, Deighan CJ, Fox JG (2002) Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure. J Am Soc Nephrol 13:2125–2132PubMedCrossRef
9.
Zurück zum Zitat Beddhu S, Samore MH, Roberts MS et al (2003) Impact of timing of initiation of dialysis on mortality. J Am Soc Nephrol 14:2305–2312PubMedCrossRef Beddhu S, Samore MH, Roberts MS et al (2003) Impact of timing of initiation of dialysis on mortality. J Am Soc Nephrol 14:2305–2312PubMedCrossRef
10.
Zurück zum Zitat Stel VS, Dekker FW, Ansell D et al (2009) Residual renal function at the start of dialysis and clinical outcomes. Nephrol Dial Transpl 24:3175–3182CrossRef Stel VS, Dekker FW, Ansell D et al (2009) Residual renal function at the start of dialysis and clinical outcomes. Nephrol Dial Transpl 24:3175–3182CrossRef
11.
Zurück zum Zitat Lassalle M, Labeeuw M, Frimat L et al (2010) Age and comorbidity may explain the paradoxical association of an early dialysis start with poor survival. Kidney Int 77:700–707PubMedCrossRef Lassalle M, Labeeuw M, Frimat L et al (2010) Age and comorbidity may explain the paradoxical association of an early dialysis start with poor survival. Kidney Int 77:700–707PubMedCrossRef
12.
Zurück zum Zitat Kazmi WH, Gilbertson DT, Obrador GT et al (2005) Effect of comorbidity on the increased mortality associated with early initiation of dialysis. Am J Kidney Dis 46:887–896PubMedCrossRef Kazmi WH, Gilbertson DT, Obrador GT et al (2005) Effect of comorbidity on the increased mortality associated with early initiation of dialysis. Am J Kidney Dis 46:887–896PubMedCrossRef
13.
Zurück zum Zitat McIntyre CW, Rosansky SJ (2012) Starting dialysis is dangerous: how do we balance the risk? Kidney Int 82:382–387PubMedCrossRef McIntyre CW, Rosansky SJ (2012) Starting dialysis is dangerous: how do we balance the risk? Kidney Int 82:382–387PubMedCrossRef
14.
Zurück zum Zitat Korevaar JC, Jansen MA, Dekker FW et al (2001) When to initiate dialysis: effect of proposed US guidelines on survival. Lancet 358:1046–1050PubMedCrossRef Korevaar JC, Jansen MA, Dekker FW et al (2001) When to initiate dialysis: effect of proposed US guidelines on survival. Lancet 358:1046–1050PubMedCrossRef
15.
Zurück zum Zitat Cooper BA, Branley P, Bulfone L et al (2010) A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 363:609–619PubMedCrossRef Cooper BA, Branley P, Bulfone L et al (2010) A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 363:609–619PubMedCrossRef
16.
Zurück zum Zitat Lameire N, Van Biesen W (2010) The initiation of renal-replacement therapy—just-in-time delivery. N Engl J Med 363:678–680PubMedCrossRef Lameire N, Van Biesen W (2010) The initiation of renal-replacement therapy—just-in-time delivery. N Engl J Med 363:678–680PubMedCrossRef
17.
Zurück zum Zitat National Kidney Foundation (2002) KDOQI clinical practice guidelines for chronic kidney disease evaluation classification and stratification. AJKD S1:S57 National Kidney Foundation (2002) KDOQI clinical practice guidelines for chronic kidney disease evaluation classification and stratification. AJKD S1:S57
18.
Zurück zum Zitat Levey AS, Coresh J, Greene T et al (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247–254PubMedCrossRef Levey AS, Coresh J, Greene T et al (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247–254PubMedCrossRef
19.
Zurück zum Zitat Goldstein M, Yassa T, Dacouris N, McFarlane P (2003) Multidisciplinary predialysis care and morbidity and mortality of patients on dialysis. Am J Kidney Dis 44:706–714CrossRef Goldstein M, Yassa T, Dacouris N, McFarlane P (2003) Multidisciplinary predialysis care and morbidity and mortality of patients on dialysis. Am J Kidney Dis 44:706–714CrossRef
20.
Zurück zum Zitat Curtis BM, Ravani P, Malberti F et al (2005) The short and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patients outcomes. Nephrol Dial Transpl 20:147–154CrossRef Curtis BM, Ravani P, Malberti F et al (2005) The short and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patients outcomes. Nephrol Dial Transpl 20:147–154CrossRef
21.
Zurück zum Zitat Devins GM, Mendelssohn DC, Barrè PE, Taub K, Binik YM (2005) Predialysis psychoeducational intervention extends survival in CKD: a 20-year follow-up. Am J Kidney Dis 46:1088–1098PubMedCrossRef Devins GM, Mendelssohn DC, Barrè PE, Taub K, Binik YM (2005) Predialysis psychoeducational intervention extends survival in CKD: a 20-year follow-up. Am J Kidney Dis 46:1088–1098PubMedCrossRef
22.
Zurück zum Zitat Brunori G, Viola BF, Parrinello G et al (2007) Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study. Am J Kidney Dis 49:569–580PubMedCrossRef Brunori G, Viola BF, Parrinello G et al (2007) Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study. Am J Kidney Dis 49:569–580PubMedCrossRef
23.
Zurück zum Zitat Pizzarelli F, Lauretani F, Bandinelli S et al (2009) Predictivity of survival according to different equations for estimating renal function in community-dwelling elderly subjects. Nephrol Dial Transpl 24:1197–1205CrossRef Pizzarelli F, Lauretani F, Bandinelli S et al (2009) Predictivity of survival according to different equations for estimating renal function in community-dwelling elderly subjects. Nephrol Dial Transpl 24:1197–1205CrossRef
24.
Zurück zum Zitat O’Hare AM, Choi AI, Bertenthal D et al (2007) Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 18:2758–2765PubMedCrossRef O’Hare AM, Choi AI, Bertenthal D et al (2007) Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 18:2758–2765PubMedCrossRef
25.
Zurück zum Zitat Chandna SM, Da Silva-Gane M, Marshall C, Warwicker P, Greenwood RN, Farrington K (2011) Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy. Nephrol Dial Transpl 26:1608–1614CrossRef Chandna SM, Da Silva-Gane M, Marshall C, Warwicker P, Greenwood RN, Farrington K (2011) Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy. Nephrol Dial Transpl 26:1608–1614CrossRef
Metadaten
Titel
Structured clinical follow-up for CKD stage 5 may safely postpone dialysis
verfasst von
Pietro Dattolo
Stefano Michelassi
Marco Amidone
Marco Allinovi
Lorenzo Vignali
Giulia Antognoli
Rosa Roperto
Francesco Pizzarelli
Publikationsdatum
01.08.2015
Verlag
Springer International Publishing
Erschienen in
Journal of Nephrology / Ausgabe 4/2015
Print ISSN: 1121-8428
Elektronische ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-014-0123-7

Weitere Artikel der Ausgabe 4/2015

Journal of Nephrology 4/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.